Two out of 10 tested cases by NGS exhibited co-amplification at 9p24.1: One case (DLBCL) harbored co-amplification of PD-L1 and PD-L2 without JAK2 gene alterations while another DLBCL case had co-amplification of all three genes. This evidence concerns the gene JAK2 and diffuse large B-cell lymphoma.